• WKN: 927200
  • ISIN: GB0059822006
  • Land: United Kingdom

Nachricht vom 12.10.2021 | 11:00


DGAP-News: Dialog Semiconductor Plc. / Key word(s): Miscellaneous
12.10.2021 / 11:00
The issuer is solely responsible for the content of this announcement.

London - 12 October 2021. Dialog Semiconductor Limited (formerly Dialog Semiconductor Plc) ("Dialog"), today announced that it supplements its announcement of 4 January 2021 in respect of the choice of the Federal Republic of Germany (Germany) as its EU home member state for purpose of the EU-Transparency Directive as follows:

Dialog commits (i) to publish Dialog's single-entity financial statements including an income statement for the financial year ended on 31 December 2020 prepared in accordance with
UK FRS 101 (EU-adopted IFRS with reduced disclosure requirements) and (ii) commits to prepare its half-yearly report for the period ended on 2 July 2021 in accordance with Section 4 of the UK Disclosure Guidance and Transparency Rules (DTR), in each case to comply with the applicable financial reporting obligations pursuant to Sec. 114 et seqq. German Securities Trading Act (Wertpapierhandelsgesetz).

This announcement is solely made to comply with the financial reporting obligations pursuant to Sec. 114 et seqq. German Securities Trading Act applicable to Dialog's annual financial report for the year ended on 31 December 2020 and its half-yearly financial report for the period ended on
2 July 2021. Dialog's continuing obligations under the German Securities Trading Act lapsed as a result of the delisting of Dialog from the regulated market of the Frankfurt Stock Exchange on
2 September 2021.

The corporate headquarters of Dialog remains located in Reading, United Kingdom.



Dialog and the Dialog logo are trademarks of Dialog Semiconductor Limited or its subsidiaries. All other product or service names are the property of their respective owners. (c) Copyright 2021 Dialog Semiconductor. All rights reserved.

12.10.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021